Science
3 Things About CRISPR Therapeutics That Smart Investors Know – The Motley Fool
The company’s value isn’t reflected in typical performance metrics.

The gene-editing virtuoso CRISPR Therapeutics (NASDAQ:CRSP) is one of the most-watched stocks in biotech, and it’s no surprise why. CRISPR Therapeutics has a handful of different programs that could turn out to be low-risk cures for previously intractable…
Continue Reading
-
General18 hours ago
Matildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News20 hours ago
Search for man who ‘faked death’ slowed by unusual French law
-
Noosa News22 hours ago
Australia’s biggest sheep drive, and the young drover history forgot
-
Noosa News18 hours ago
Police appeal for information after two men found dead